Drug Shortage Report for DEXTROSE INJECTION USP

Last updated on 2020-01-30 History
Report ID 91585
Drug Identification Number 02468514
Brand name DEXTROSE INJECTION USP
Common or Proper name DEXTROSE INJECTION
Company Name PFIZER CANADA ULC
Market Status
Active Ingredient(s) DEXTROSE
Strength(s) 500 mg/mL
Dosage form(s) Solution
Route of administration Intravenous
Packaging size 10 X 50ml ANSYR
ATC code B05BA
ATC description I.V. Solutions
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-08-14
Estimated end date
Actual end date 2020-01-29
Shortage status Resolved
Updated date 2020-01-30
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-01-30 French Compare
v4 2020-01-30 English Compare
v3 2019-08-15 English Compare
v2 2019-08-14 French Compare
v1 2019-08-14 English Compare